Literature DB >> 20335238

Mitochondrial encephalocardio-myopathy with early neonatal onset due to TMEM70 mutation.

Tomás Honzík1, Markéta Tesarová, Johannes A Mayr, Hana Hansíková, Pavel Jesina, Olaf Bodamer, Johannes Koch, Martin Magner, Peter Freisinger, Martina Huemer, Olga Kostková, Rudy van Coster, Stanislav Kmoch, Josef Houstêk, Wolfgang Sperl, Jirí Zeman.   

Abstract

OBJECTIVE: Mitochondrial disturbances of energygenerating systems in childhood are a heterogeneous group of disorders. The aim of this multi-site survey was to characterise the natural course of a novel mitochondrial disease with ATP synthase deficiency and mutation in the TMEM70 gene.
METHODS: Retrospective clinical data and metabolic profiles were collected and evaluated in 25 patients (14 boys, 11 girls) from seven European countries with a c.317-2A-->G mutation in the TMEM70 gene.
RESULTS: Severe muscular hypotonia (in 92% of newborns), apnoic spells (92%), hypertrophic cardiomyopathy (HCMP; 76%) and profound lactic acidosis (lactate 5-36 mmol/l; 92%) with hyperammonaemia (100-520 micromol/l; 86%) were present from birth. Ten patients died within the first 6 weeks of life. Most patients surviving the neonatal period had persisting muscular hypotonia and developed psychomotor delay. HCMP was non-progressive and even disappeared in some children. Hypospadia was present in 54% of the boys and cryptorchidism in 67%. Increased excretion of lactate and 3-methylglutaconic acid (3-MGC) was observed in all patients. In four surviving patients, life-threatening hyperammonaemia occurred during childhood, triggered by acute gastroenteritis and prolonged fasting.
CONCLUSIONS: ATP synthase deficiency with mutation in TMEM70 should be considered in the diagnosis and management of critically ill neonates with early neonatal onset of muscular hypotonia, HCMP and hypospadias in boys accompanied by lactic acidosis, hyperammonaemia and 3-MGC-uria. However, phenotype severity may vary significantly. The disease occurs frequently in the Roma population and molecular-genetic analysis of the TMEM70 gene is sufficient for diagnosis without need of muscle biopsy in affected children.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335238     DOI: 10.1136/adc.2009.168096

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

Review 1.  Metabolic biology of 3-methylglutaconic acid-uria: a new perspective.

Authors:  Betty Su; Robert O Ryan
Journal:  J Inherit Metab Dis       Date:  2014-01-10       Impact factor: 4.982

Review 2.  Treatment options for lactic acidosis and metabolic crisis in children with mitochondrial disease.

Authors:  Katharina Danhauser; Jan A M Smeitink; Peter Freisinger; Wolfgang Sperl; Hemmen Sabir; Berit Hadzik; Ertan Mayatepek; Eva Morava; Felix Distelmaier
Journal:  J Inherit Metab Dis       Date:  2015-02-17       Impact factor: 4.982

3.  Mitochondrial disease--an important cause of end-stage renal failure.

Authors:  Shamima Rahman; Andrew M Hall
Journal:  Pediatr Nephrol       Date:  2012-12-12       Impact factor: 3.714

Review 4.  Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature.

Authors:  Saskia B Wortmann; Marinus Duran; Yair Anikster; Peter G Barth; Wolfgang Sperl; Johannes Zschocke; Eva Morava; Ron A Wevers
Journal:  J Inherit Metab Dis       Date:  2013-01-08       Impact factor: 4.982

5.  Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis.

Authors:  Tomas Honzik; Marketa Tesarova; Martin Magner; Johannes Mayr; Pavel Jesina; Katerina Vesela; Laszlo Wenchich; Karol Szentivanyi; Hana Hansikova; Wolfgang Sperl; Jiri Zeman
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

Review 6.  The mitochondrial phosphate carrier: Role in oxidative metabolism, calcium handling and mitochondrial disease.

Authors:  Erin L Seifert; Erzsébet Ligeti; Johannes A Mayr; Neal Sondheimer; György Hajnóczky
Journal:  Biochem Biophys Res Commun       Date:  2015-06-16       Impact factor: 3.575

7.  TMEM70 deficiency: long-term outcome of 48 patients.

Authors:  Martin Magner; Veronika Dvorakova; Marketa Tesarova; Stella Mazurova; Hana Hansikova; Martin Zahorec; Katarina Brennerova; Vladimir Bzduch; Ronen Spiegel; Yoseph Horovitz; Hanna Mandel; Fatma Tuba Eminoğlu; Johannes Adalbert Mayr; Johannes Koch; Diego Martinelli; Enrico Bertini; Vassiliki Konstantopoulou; Joél Smet; Shamima Rahman; Alexander Broomfield; Vesna Stojanović; Carlo Dionisi-Vici; Rudy van Coster; Eva Morava; Eva Morava-Kozicz; Wolfgang Sperl; Jiri Zeman; Tomas Honzik
Journal:  J Inherit Metab Dis       Date:  2014-10-18       Impact factor: 4.982

Review 8.  The 3-methylglutaconic acidurias: what's new?

Authors:  Saskia B Wortmann; Leo A Kluijtmans; Udo F H Engelke; Ron A Wevers; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2010-09-30       Impact factor: 4.982

Review 9.  Mitochondrial ATP synthase: architecture, function and pathology.

Authors:  An I Jonckheere; Jan A M Smeitink; Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2011-08-27       Impact factor: 4.982

10.  Common and Novel TMEM70 Mutations in a Cohort of Italian Patients with Mitochondrial Encephalocardiomyopathy.

Authors:  Daria Diodato; Federica Invernizzi; Eleonora Lamantea; Gigliola Fagiolari; Rossella Parini; Francesca Menni; Giancarlo Parenti; Lina Bollani; Elisabetta Pasquini; Maria A Donati; Denise Cassandrini; Filippo M Santorelli; Tobias B Haack; Holger Prokisch; Daniele Ghezzi; Costanza Lamperti; Massimo Zeviani
Journal:  JIMD Rep       Date:  2014-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.